Jingcheng Dong

21PUBLICATIONS
16CO-AUTHORS
AllergySystems physiologyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 10, 2026
Eosinophil diversity and function: emerging insights into subtypes and therapeutic targets.

|Jul 01, 2026
A Nomogram Model for Predicting Moderate to Severe OSA in Western China: A Retrospective Analysis.

|Dec 18, 2025
Icariin Inhibits NF-κB Signaling in Asthmatic Lung Epithelium by Promoting Nrf2 Signaling.

Shiyuan Wang, Huijie Zhang, Weifeng Tang

|Aug 13, 2024
Music Therapy and Music Intervention for NSCLC Patients Undergoing PET with Fear of Cancer Recurrence.

Yi-Jie Du, Yi-Hui Guan, Kevin T Thome

|Jul 09, 2024
Icariin attenuates asthmatic airway inflammation via modulating alveolar macrophage activation based on network pharmacology and in vivo experiments.

Xiaofei Zhu, Bin Wang, Hang Yu

|Jul 05, 2024
Icariside II in NSCLC and COVID-19: Network pharmacology and molecular docking study.

Qing Kong, Huahe Zhu, Jingcheng Dong

Pageof 4

Frequent Collaborators

3 joint publications

Ying Wei

2 joint publications

Baojun Liu

2 joint publications

Jing Sun

2 joint publications

Muhua Huang